Black Diamond Therapeutics, Inc. (BDTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.04
Day's range
$2.18

Black Diamond Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 10.56 M $22.50 M   -0.41% 18.50%
NEA MANAGEMENT COMPANY, LLC 05/15/2026 4.45 M $9.48 M   0.00% 7.79%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 2.35 M $5.00 M   44.07% 4.11%
05/15/2026 1.85 M $3.94 M   100.00% 3.24%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.64 M $3.50 M   73.07% 2.88%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.30 M $2.77 M   51.88% 2.28%
BLACKROCK, INC. 05/13/2026 1.11 M $2.36 M   24.61% 1.94%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 1.06 M $2.25 M   61.66% 1.85%
MACKENZIE FINANCIAL CORP 05/13/2026 844.84 K $1.80 M   139.70% 1.48%
MARSHALL WACE, LLP 05/15/2026 836.27 K $1.78 M   -24.67% 1.46%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 834.57 K $1.78 M   -19.79% 1.46%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 723.48 K $1.54 M   317.47% 1.27%
GOLDMAN SACHS GROUP INC 05/15/2026 684.42 K $1.46 M   110.38% 1.20%
FMR LLC 05/15/2026 623.83 K $1.33 M   15.28% 1.09%
UBS GROUP AG 05/05/2026 564.84 K $1.20 M   119.24% 0.99%
MAN GROUP PLC 05/15/2026 559.70 K $1.19 M   330.43% 0.98%
WINTON GROUP LTD 05/12/2026 538.26 K $1.15 M   27.77% 0.94%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 536.58 K $1.14 M   6.09% 0.94%
AWM INVESTMENT COMPANY, INC. 05/15/2026 525.00 K $1.12 M   -16.00% 0.92%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 510.81 K $1.09 M   100.00% 0.89%
CITADEL ADVISORS LLC 05/15/2026 502.65 K $1.07 M   18.14% 0.88%
NORTHERN TRUST CORP 05/14/2026 464.71 K $989.83 K   -1.69% 0.81%
D. E. SHAW & CO., INC. 05/15/2026 363.92 K $775.15 K   -44.50% 0.64%
GLOBEFLEX CAPITAL L P 05/13/2026 305.28 K $650.24 K   0.00% 0.53%
STIFEL FINANCIAL CORP 05/12/2026 278.65 K $593.52 K   1.33% 0.49%
ROUND ROCK ADVISORS, LLC 05/15/2026 274.37 K $584.40 K   120.26% 0.48%
VANGUARD FIDUCIARY TRUST CO 05/15/2026 259.91 K $553.60 K   100.00% 0.46%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 247.96 K $528.15 K   0.00% 0.43%
EMPOWERED FUNDS, LLC 06/16/2026 230.18 K $490.28 K   100.00% 0.40%
STATE STREET CORP 05/15/2026 213.51 K $454.78 K   0.00% 0.37%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2026 211.40 K $450.28 K   4.09% 0.37%
TD ASSET MANAGEMENT INC 05/11/2026 195.93 K $417.33 K   0.00% 0.34%
BANK OF NEW YORK MELLON CORP 05/05/2026 189.15 K $402.89 K   -11.89% 0.33%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 05/13/2026 182.24 K $388.16 K   -48.59% 0.32%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 05/15/2026 173.65 K $369.87 K   9.22% 0.30%
GRAHAM CAPITAL MANAGEMENT, L.P. 05/15/2026 170.90 K $364.02 K   97.44% 0.30%
GSA CAPITAL PARTNERS LLP 05/08/2026 169.77 K $362.00 K   -30.91% 0.30%
RITHOLTZ WEALTH MANAGEMENT 04/20/2026 165.33 K $352.16 K   -27.44% 0.29%
MILLENNIUM MANAGEMENT LLC 05/15/2026 134.98 K $287.51 K   -54.48% 0.24%
BANK OF AMERICA CORP /DE/ 05/18/2026 114.14 K $243.13 K   123.36% 0.20%
INVESCO LTD. 05/12/2026 107.40 K $228.76 K   -18.29% 0.19%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 100.99 K $215.10 K   -48.67% 0.18%
JANE STREET GROUP, LLC 05/12/2026 94.83 K $201.99 K   -90.14% 0.17%
05/15/2026 93.18 K $198.47 K   100.00% 0.16%
AMERICAN CENTURY COMPANIES INC 05/15/2026 91.05 K $193.93 K   -15.78% 0.16%
CITADEL ADVISORS LLC 05/15/2026 90.90 K $193.62 K   73.47% 0.16%
MORGAN STANLEY 05/15/2026 88.62 K $188.77 K   -6.86% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 78.86 K $167.97 K   -24.70% 0.14%
BARCLAYS PLC 05/15/2026 67.28 K $143.30 K   -10.07% 0.12%
OMERS ADMINISTRATION CORP 05/15/2026 62.80 K $133.76 K   -54.79% 0.11%

Black Diamond Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 142 institutional investors and hedge funds held shares of Black Diamond Therapeutics Inc. The most heavily invested institutionals were:

T. Rowe Price Investment Management, Inc.: 10.56 M

NEA Management Company, LLC: 4.45 M

ACADIAN ASSET MANAGEMENT LLC: 2.35 M

RENAISSANCE TECHNOLOGIES LLC: 1.64 M

DIMENSIONAL FUND ADVISORS LP: 1.3 M

BlackRock, Inc.: 1.11 M

67.46% of Black Diamond Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 43.87 M shares in the last 24 months. This purchase volume represents approximately $95.64 M in transactions.